kogenate is used to treat hemophilia type A by replacing the deficiency of clotting factor VIII in the blood. This helps control bleeding, reduce blood loss, and support normal blood clotting. It also helps prevent recurrent bleeding and protects joints when used regularly under medical supervision.
This treatment helps improve the health stability of patients with clotting disorders. kogenate in uae reduces the risk of spontaneous bleeding and supports a safer ability to perform daily activities. It also contributes to maintaining joint health and improving long-term quality of life.